Literature DB >> 2298504

Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients.

H Beerman1, P M Kluin, J Hermans, C J van de Velde, C J Cornelisse.   

Abstract

Flow cytometric DNA-ploidy measurements were performed on paraffin-embedded and fresh tumor specimens from 690 patients with Stage I-III breast cancer. The conventional classification of DNA-ploidy (diploid versus aneuploid) was compared with a division of tumor ploidy into 5 classes based on DNA index (DI) range. The DI-classification showed a better correlation with tumor size and TNM stage than the conventional classification. Aneuploidy was associated with an impaired survival and distant relapse-free survival (p = 0.02) but the DI-classification improved the discrimination between different prognostic groups of patients. In general, this indicated a more aggressive phenotype for tumors evolved via polyploidization. Hyper-tetraploidy (DI greater than 2.10) indicated a very poor prognosis in pre-menopausal patients. No prognostic effect of aneuploidy and DI-class was found in node-negative and TI patients. Cox multivariate regression analysis showed that aneuploidy was an additional prognostic factor to nodal status (I less than or equal to N less than or equal to 3, N greater than 3 vs. N = 0) and tumor size (T2-4 vs. TI) for overall and distant relapse-free survival. Subdivision according to DI-class did not improve the prognostic power of DNA-ploidy due to stronger correlations with established prognostic factors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2298504     DOI: 10.1002/ijc.2910450108

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  25 in total

1.  Prognostic significance of cell cycle parameters in infiltrative ductal breast carcinoma.

Authors:  B Uzarević; M Petrovecki; M Marusić; J Jakić-Razumović; Z Hutinec; A Sabioncello; S Gamulin
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

2.  Lymph node metastases versus DNA ploidy as prognostic factors for invasive ductal carcinoma of the breast.

Authors:  M Noguchi; T Taniya; N Ohta; N Koyasaki; I Miyazaki; Y Mizukami
Journal:  Breast Cancer Res Treat       Date:  1991-09       Impact factor: 4.872

3.  Genetic variation in the major mitotic checkpoint genes and risk of breast cancer: a multigenic study on cancer susceptibility.

Authors:  Ping Wang; Yong Wang; Haichao Yan; Qiuping Xie; Liang Zhao; Shaoming Xu; Qunzi Zhao
Journal:  Tumour Biol       Date:  2014-04-08

4.  Analysis of DNA and morphometry in breast carcinoma.

Authors:  M Aubele; G Auer; H Höfler
Journal:  Histochem Cell Biol       Date:  1996-08       Impact factor: 4.304

5.  DNA ploidy analyses in 218 consecutive Pakistani breast cancer patients: does it add anything?

Authors:  E Khan; Z Mapara; S Khan; N Arshad; T Siddiqui; S Pervez
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

6.  A retrospective study on the clinical and biological prediction of axillary lymph node metastasis in breast cancer.

Authors:  M Noguchi; N Ohta; M Thomas; H Kitagawa; M Earashi; I Miyazaki; Y Mizukami
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

7.  Markers of prognosis in breast cancer--the relationship between binding of the lectin HPA and histological grade, SPF, and ploidy.

Authors:  S A Brooks; A J Leathem; R S Camplejohn; W Gregory
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

8.  DNA ploidy and S-phase fraction in medullary carcinoma of the breast--a flow cytometric analysis using archival material.

Authors:  L Pedersen; J K Larsen; I J Christensen; A Lykkesfeldt; S Holck; T Schiødt
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

9.  Improved prognostication in small (pT1) breast cancers by image cytometry.

Authors:  M Aubele; G Auer; U Falkmer; A Voss; K Rodenacker; L E Rutquist; H Höfler
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

Review 10.  DNA Cytometry Consensus Conference. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast.

Authors:  D W Hedley; G M Clark; C J Cornelisse; D Killander; T Kute; D Merkel
Journal:  Breast Cancer Res Treat       Date:  1993-10       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.